entertainment -WSS

entertainment

author：leisure time 2025-10-01 12:11:53 - browse：9588

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Today, we explore the future of obesity drugs and how they’re named, we chat with CRISPR pioneers about what it’s like to see the technology approved for human use, and more.

The need-to-know this morning:
• Bayer said it prematurely stopped a Phase 3 study in stroke prevention after independent monitors concluded its experimental blood-thinning medicine, called asundexian, showed inferior efficacy compared to a standard treatment. The asundexian study setback is a significant blow to Bayer’s effort to revamp its drug-development pipeline, analysts said.
• Carmot Therapeutics filed paperwork Friday for an initial public offering of undisclosed size. The Berkeley, Calif.-based company is developing drugs that target GLP-1 and GIP to treat diabetes and obesity, similar to Novo Nordisk’s Ozempic/Wegovy and Eli Lilly’s Mounjaro/Zepbound.
• Bristol Myers Squibb and 2Seventy Bio said the FDA will not complete an on-time review of its application seeking to expand the use of Abecma, their CAR-T therapy for multiple myeloma. Instead, the FDA will convene an advisory panel meeting — date to be determined — to examine survival data from an Abecma clinical trial.
• The U.K. and the pharmaceutical industry have reached a deal on a five-year plan outlining how the health system pays for drugs, as the country tries to keep a lid on its medicines spending while simultaneously building up its life sciences industry. STAT’s Andrew Joseph has more here.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Meta looks to target Twitter with a rival app called Threads

WSS

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

Connecting traumatic brain injury and domestic violence

Why is France rioting? What to know about the fatal police shooting of Nahel M

Many immigrants are left out of maternal health programs

Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on

Biden has enormous polling lead in Democratic primary, despite challenge from RFK Jr.

leisure time

entertainment

explore

As demand for Covid shots wanes, Moderna seeks its next success

Many immigrants are left out of maternal health programs

Walensky prepares to leave CDC — and Congress — behind

Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on

What does generative AI mean for health care? We asked experts

China demands US invite Hong Kong leader to economic meeting, adding to strains over crackdown

Anesthesiologist group: stop taking Ozempic before surgery

When is a doctor not a doctor? Try when patients address women doctors

Apple is now the first public company to be valued at $3 trillion

A new study asks: Are we harming blood donors by taking blood?

focus

House GOP plan to stem drug shortages differs from Democrats’

5 wounded, 2 critically, in Michigan shopping center shooting

Ukraine, Russia accuse each other of planning to attack Europe's biggest nuclear plant

Van's Gluten Free Original Waffles recalled for possible wheat allergen

These geoengineering technologies could help combat the climate crisis, scientists say

Doctor appointment wait times are getting worse

hotspot

explore

focus

explore